prolif activ neuroendocrin tumour gastroenteropancreat endocrin system dna flow cytometr immunohistolog investig prolif activ tumour specimen patient neuroendocrin tumour gastroenteropancreat endocrin system dna flow cytometri immunohistolog nuclear prolifer antigen equival result method prolif activ gastroenteropancreat neuroendocrin tumour heterogen malign small intestin carcinoid extraviscer carcinoid retroperitoneum percentag index tumour cell dna flow cytometri high prolif activ malign pancreat endocrin tumour metastas indic high prolif activ benign pancreat endocrin tumour indic low prolif activ heterogen prolif activ part heterogen result chemotherapi treatment chemotherapi tumour favour cell kinet individu diagnost investig prolif activ neuroendocrin tumour valu patient suitabl treatment 